Position
S Squared Technology, LLC in Krystal Biotech, Inc.
Back to the book · All holders of KRYS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.02M$246.54 → $258.32
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 96.2K | $23.7M | — | — | — | 9.2% |
| Q1 2026 | 86.2K | $22.3M | $258.32 | $1.02M | −$2.47M | 8.4% |